Bishoy Faltas, MD

BRIN AND BRIN, PC

6223 IH10 WEST

Articles

Managing HIV Occupational Exposures: Updated Guidelines

September 06, 2013

HIV occupational exposure leads to an estimated 1000 HIV infections among healthcare workers every year worldwide.

Anti-HIV Drug Efficacy: Are There Sex Differences?

September 05, 2013

Current antiretrovial therapy is, on average, equally effective in both sexes and thus can be used in a similar way to treat HIV-infected men and women.

Physician-Patient Communication Linked to HIV Treatment Retention

August 06, 2013

For HIV/AIDS patients, adherence to scheduled clinic visits is linked with perception of quality of care.

Hereditary Breast Cancer Syndromes: When and Why to Screen and What to Say When You Don't

July 29, 2013

A healthy 50-year-old woman walks into your office; she is concerned about her risk of breast cancer because right-sided breast cancer was diagnosed in her mother at age 55. She is of Caucasian ancestry and has no other family members with breast, ovarian, or prostate cancer. She has read the news about an actress who had a “cancer gene” and ended up having prophylactic mastectomies. She is very concerned about her risk of developing breast cancer and wants to be “tested.”

Antiretroviral Therapy and Cognitive Function: Is There an Impact?

July 02, 2013

Antiretroviral therapy may not halt neurocognitive decline even in patients who have normal CD4 counts and undetectable viral loads.

Hypertension Undertreated in HIV-infected Patients, Study Finds

June 05, 2013

HIV-infected patients are undertreated for hypertension and at higher risk for cardiovascular complications than age-matched controls.

HIV Patients Continue to Suffer From Severe Fatigue Despite HAART

June 05, 2013

In HIV-infected patients receiving HAART, fatigue and orthostasis are highly prevalent.

HIV-Infected Women Have Higher Risk of Incident Invasive Cervical Cancer

May 08, 2013

Key points for primary care physicians from a new study: HIV-positive women are vulnerable to invasive cervical cancer. This finding underscores the need for screening per guidelines and to follow-up on abnormal Pap smears.